These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
995 related items for PubMed ID: 31062483
1. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study. Kim SS, Kim SH, Song KD, Choi SY, Heo NH. J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483 [Abstract] [Full Text] [Related]
2. Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules. Kim JW, Lee CH, Kim SB, Park BN, Park YS, Lee J, Park CM. J Magn Reson Imaging; 2017 Jun; 45(6):1599-1608. PubMed ID: 27726242 [Abstract] [Full Text] [Related]
3. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma. Rimola J, Forner A, Sapena V, Llarch N, Darnell A, Díaz A, García-Criado A, Bianchi L, Vilana R, Díaz-González Á, Ayuso C, Bruix J, Reig M. Eur Radiol; 2020 Jan; 30(1):186-194. PubMed ID: 31372783 [Abstract] [Full Text] [Related]
4. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease. Jang KM, Kim SH, Kim YK, Choi D. Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304 [Abstract] [Full Text] [Related]
13. Differentiating malignant from benign hyperintense nodules on unenhanced T1-weighted images in patients with chronic liver disease: using gadoxetic acid-enhanced and diffusion-weighted MR imaging. Moon JY, Kim SH, Choi SY, Hwang JA, Lee JE, Lee J. Jpn J Radiol; 2018 Aug; 36(8):489-499. PubMed ID: 29876721 [Abstract] [Full Text] [Related]
14. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors. Zarghampour M, Fouladi DF, Pandey A, Ghasabeh MA, Pandey P, Varzaneh FN, Khoshpouri P, Shao N, Pan L, Grimm R, Kamel IR. J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756 [Abstract] [Full Text] [Related]
15. Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI. Kim YN, Song JS, Moon WS, Hwang HP, Kim YK. Acta Radiol; 2018 Jun; 59(6):639-648. PubMed ID: 28825310 [Abstract] [Full Text] [Related]
16. Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma. Chou YC, Lao IH, Hsieh PL, Su YY, Mak CW, Sun DP, Sheu MJ, Kuo HT, Chen TJ, Ho CH, Kuo YT. World J Gastroenterol; 2019 Jun 07; 25(21):2636-2649. PubMed ID: 31210715 [Abstract] [Full Text] [Related]
20. Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid. Besa C, Lewis S, Pandharipande PV, Chhatwal J, Kamath A, Cooper N, Knight-Greenfield A, Babb JS, Boffetta P, Padron N, Sirlin CB, Taouli B. Abdom Radiol (NY); 2017 Jan 07; 42(1):179-190. PubMed ID: 27448609 [Abstract] [Full Text] [Related] Page: [Next] [New Search]